CHINA BRIEF | Tencent rolls out AI platform iDrug to shorten research time for new drugs

Written by Song Jingli Published on 

More than 10 projects, including potential cures for COVID-19, are currently running on iDrug.

Chinese tech giant Tencent has launched iDrug, an AI-driven software platform, to aid new medicine development, according to a press release issued by the company on Thursday.

Developed by Tencent’s AI lab, iDrug was designed to speed up the entire process of pre-clinical drug discovery with its machine learning capabilities, according to the release. The platform is made up of five models for protein structure prediction, virtual screening, generative chemistry, ADMET (absorption, distribution, metabolism, excretion and toxicity/pharmacokinetic) prediction, and synthetic route planning. The virtual screening and ADMET prediction models are already online, open to all pharmaceutical companies and research institutes for free, with the remaining three models to come online soon.

More than 10 projects—including potential cures for COVID-19 from several pharmaceutical companies—are now running on iDrug, said Tencent in the press release.

Read this: AI to boost doctors’ efficiency with imaging diagnostics: Inside China’s Startups

This article is part of KrASIA’s “China Brief” section, where KrASIA’s reporters will provide quick daily updates about the tech ecosystem in China.


You might like these

  • News

    Alibaba opens its conversational AI tech, expanding its use beyond smart speakers


    Song Jingli

    23 Oct 2020    08:59 AM

KrASIA InsightsKrASIA Insights

  • Design elements in e-commerce marketplaces create the urge to buy more and buy faster. What are the techniques that these platforms deploy?


    Dark patterns in Southeast Asian e-commerce

    By Lin Lingyi

    26 Oct 202004:07 AM

Most PopularMost Popular

See All